Method for sorting primary human marrow mesenchy malstem cell by monoclonal antibody ZUB4 immunomagnetic bead
An immunomagnetic bead sorting and bone marrow mesenchymal technology, applied in the direction of bone/connective tissue cells, animal cells, vertebrate cells, etc., can solve the complex composition of CD45-GlycophorinA-cell population and the difficulty of immunolabeling to be directly sorted. The ideal labeling of human bone marrow MSCs, the difficulty of practical application of MSCs isolation and purification, etc., achieve the effect of good growth activity and proliferation potential, improve the time-consuming, and shorten the culture time.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0022] Separation of primary human bone marrow MSCs by immunomagnetic beads with monoclonal antibody ZUB4
[0023] Bone marrow was collected from a healthy donor, heparin anticoagulant, Ficoll-paque (specific gravity 1.077) density gradient centrifugation to obtain bone marrow mononuclear cells, and monoclonal antibody ZUB4 (antibody subtype IgG1) disclosed in patent application number 200510061036.1 was used to combine with bone marrow mononuclear cells Nucleated cells were incubated, centrifuged and washed, then incubated with anti-mouse IgG magnetic bead secondary antibody (Miltenyi Biotec Inc.), centrifuged and washed, and isolated from bone marrow mononuclear cells by immunomagnetic bead sorting system to obtain ZUB4 antigen-positive human bone marrow MSCs. ZUB4 antigen-positive cells and negative cells were inoculated on culture dishes respectively, and placed in low-sugar DMEM medium containing 10% (V / V) fetal bovine serum at 37°C with a volume fraction of 5% CO 2 Cultu...
Embodiment 2
[0027] Analysis of the proliferation ability of positive cells obtained by forward immune sorting using ZUB4 as a marker
[0028] Take the ZUB4-positive human bone marrow MSCs first and fifth generation cells cultured in vitro, and press 2×10 4 Cells / well density were seeded in 24-well culture plates, cultured for 1, 2, 3, 4, 5, 6, 7, and 8 days, and cell kinetics analysis was performed. The culture has the following common characteristics: After the cells are subcultured, the cells are completely attached to the wall in about 10 hours, and the cell shape becomes a spindle cell again; the incubation period of the subculture is about 24 to 36 hours; days; after the end of the logarithmic growth phase, it enters the plateau phase; there is no significant difference between the growth of the fifth generation and the first generation cells, see figure 2 . Positive cells obtained by forward immune sorting with ZUB4 as a marker have good proliferative activity and maintain a spin...
Embodiment 3
[0030] Phenotypic characteristics of positive cells obtained by forward immuno-sorting using ZUB4 as marker
[0031] The first and fifth passages of ZUB4-positive human bone marrow MSCs cultured and passaged in vitro were used as CD14-FITC, CD29-PE, CD34-PE, CD44-FITC, CD45-FITC, CD105-PE, CD166-PE, HLA -DR-FITC monoclonal antibody was used as a probe, and the expression of MSCs surface molecules was analyzed by flow cytometry. The results showed that CD29, CD44, CD166, and CD105 (SH2) positive markers showed a single peak, and the expressions of hematopoietic cell differentiation antigens CD14, CD34, CD45, and HLA-DR were all negative, see image 3 , image 3 The immunophenotype analysis of the positive cells obtained after forward immunosorting marked with ZUB4 was expanded to the fifth passage in vitro. The phenotypic characteristics of positive cells after forward immuno-sorting with ZUB4 are those of human bone marrow MSCs, and there is no significant difference in the ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com